Cart
sales@molnova.com
Phenetole
CAS No. 103-73-1
Phenetole( NSC 406706 | NSC-406706 | NSC406706 )
Catalog No. M23245 CAS No. 103-73-1
Phenetole is used as an analyte to determine the properties of porous graphite carbon (PGC) particles.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 5MG | 45 | In Stock |
|
| 10MG | 68 | In Stock |
|
| 25MG | 115 | In Stock |
|
| 50MG | 173 | In Stock |
|
| 100MG | 258 | In Stock |
|
| 200MG | 388 | In Stock |
|
| 500MG | 642 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePhenetole
-
NoteResearch use only, not for human use.
-
Brief DescriptionPhenetole is used as an analyte to determine the properties of porous graphite carbon (PGC) particles.
-
DescriptionPhenetole is used as an analyte to determine the properties of porous graphite carbon (PGC) particles.
-
In Vitro——
-
In Vivo——
-
SynonymsNSC 406706 | NSC-406706 | NSC406706
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number103-73-1
-
Formula Weight122.17
-
Molecular FormulaC8H10O
-
Purity>98% (HPLC)
-
SolubilityDMSO:Soluble
-
SMILESCCOC1=CC=CC=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Methenolone acetate
Methenolone acetate is an androgen and anabolic steroid (AAS) medication which is used mainly in the treatment of anemia due to bone marrow failure.
-
4-(9H-fluoren-9-ylme...
4-(9H-fluoren-9-ylmethoxycarbonylamino)-piperidine-1,4-dicarboxylic acid mono-tert-butyl ester is a substituted piperidine derivative widely used in organic synthesis as a linker to form peptide and peptidomimetic molecules.
-
MAGE-A3 195-203
This peptide MAGE-3-encoded HLA-A24 epitope is a high MHC binder.The identification of this MAGE-3/HLA-A24 peptide may as a result effectiveially offer the opportunities to design peptide-based immunotherapeutic approaches that might prove to be potent in treating patients with MAGE-3-positive malignant tumors.
